Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma

Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma

Immune and inflammatory cascades may play multiple roles in ovarian cancer. We aimed to identify relationships between expression of immune and inflammatory mediators and patient outcomes. We interrogated differential gene expression of 44 markers and marker combinations (n = 1,978) in 1,656 ovarian...

Full description

Bibliographic Details
Main Authors: Mano Nakamura, Heather J. Bax, Daniele Scotto, Elmira Amiri Souri, Sam Sollie, Robert J. Harris, Niklas Hammar, Goran Walldius, Anna Winship, Sharmistha Ghosh, Ana Montes, James F. Spicer, Mieke Van Hemelrijck, Debra H. Josephs, Katie E. Lacy, Sophia Tsoka, Sophia N. Karagiannis
Format: Article
Language:English
Published: Taylor & Francis Group 2019-06-01
Series:OncoImmunology
Subjects:
immune activation
ovarian cancer
immune mediators
inflammation
th1/th2/th17
m1/m2
biomarkers
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1593811

Internet

http://dx.doi.org/10.1080/2162402X.2019.1593811

Similar Items